Thursday, May 8, 2025

12:30 PM - 1:15 PM

C2.5 & C2.6

---

Details

This session will explore new and emerging technologies, as well as the regulatory and reimbursement challenges, discussing whether current processes are agile enough to keep up with this rapidly growing field. Precision Medicine – The role of radiotheranostics in supporting the use of radiotherapeutics for more targeted and precise cancer treatments. Personalised Medicine – The growing role of 'omics' technologies, including pharmacogenomics, in matching the right therapies to the right patients. The presentation will explore the increasing need for biomarkers to support the advancement of personalised treatment strategies. Therapeutic Drug Monitoring – The role of diagnostics in the development of new therapies, highlighting successful collaborations between pharmaceuticals and medical devices.

---

Speaker